ANYO Labs is focused on virtual screening and de novo small molecular drug generation in early-stage drug discovery projects. The unparalleled computational efficiency of our predictions opens up avenues never explored before allowing for data efficient and cost efficient hit identification.
Supporting modules help aid hit-to-lead and lead optimization, while the PPI module can find correlations between hundreds of proteins simultaneously.
Get in touch! We are open to discussing your potential projects, collaborations, or discuss any questions you might have.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Vera Sandbergs Allé 8a, Gothenburg,vastra Gotaland County 411 33,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.anyolabs.com
- Keywords
- Drug Discovery, AI, Machine Learning, Target to Hit, Hit to Lead, ADMET, Biotech, virtual screening, pharmaceutical, small molecules, omics, preclinical, lead optimization.
- HQ
- Gothenburg, Vastra Gotaland County
Anyo Labs Questions
Anyo Labs's website is http://www.anyolabs.com
Anyo Labs's LinkedIn profile is https://se.linkedin.com/company/anyo-labs
Anyo Labs has
13 employees.
View email and phone details for 13
employees at Anyo Labs.
Anyo Labs's industry is
Biotechnology Research
Anyo Labs's top competitors are
Zymego,
Addi Medical Ab,
H1,
Sownder,
Videm,
Scale Up Life Science Invest,
Neogap Therapeutics Ab,
Ironic Biotech,
Brainzell,
0+x.
Anyo Labs's categories are Biotechnology Research
Anyo Labs's founding year is 2022
